A detailed history of Boomfish Wealth Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Boomfish Wealth Group, LLC holds 1,398 shares of ABBV stock, worth $240,078. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,398
Previous 1,452 3.72%
Holding current value
$240,078
Previous $249 Million 10.85%
% of portfolio
0.17%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $8,847 - $10,763
-54 Reduced 3.72%
1,398 $276 Million
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $2,476 - $2,892
-16 Reduced 1.09%
1,452 $249 Million
Q1 2024

May 03, 2024

BUY
$159.82 - $182.1 $639 - $728
4 Added 0.27%
1,468 $267 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $201,446 - $226,876
1,464 New
1,464 $227 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Boomfish Wealth Group, LLC Portfolio

Follow Boomfish Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boomfish Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boomfish Wealth Group, LLC with notifications on news.